Monitoring patients with precursors to gastric cancer
Official title: SUrveillance of PREMalignant Stomach - Individualized Endoscopic Follow-up
Run by Instituto Portugues de Oncologia, Francisco Gentil, Porto · NCT04613570 · Data updated 2026-11-12
This study is testing the best ways to monitor people over 45 with early signs of stomach cancer to help keep them safe and healthy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years and up |
| Sex | All |
| Enrollment | 912 (estimated) |
| Sponsor | Instituto Portugues de Oncologia, Francisco Gentil, Porto Academic / other |
| Locations | 1 site (Porto) |
| Status | Recruiting |
| Started | January 2, 2021 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | March 31, 2022 |
| Trial ID | NCT04613570 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals over 45 years old with known gastric premalignant conditions scheduled for upper GI endoscopy.
✕Probably not a fit
Patients with a history of previous gastrectomy, endoscopic resection of neoplastic lesions, or hereditary syndromes increasing gastric cancer risk may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate patients with premalignant gastric conditions, such as atrophic gastritis and intestinal metaplasia, to determine the best methods for their identification and follow-up. It will utilize high-resolution endoscopy and validated histological scales to assess the risk of gastric cancer over time. The study will involve multiple gastroenterology departments across various countries and will focus on patients over 45 years old who are scheduled for upper gastrointestinal endoscopy. By analyzing clinical, histological, and endoscopic factors, the study seeks to establish optimal surveillance protocols for these patients.
Why it matters
Potential benefit: If successful, this study could lead to improved surveillance strategies that reduce the risk of gastric cancer in at-risk patients.
How similar studies have gone: Other studies have shown success in using endoscopic surveillance for gastric cancer precursors, but this approach is novel in its comprehensive evaluation of multiple factors.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients scheduled for upper GI endoscopy with indication for gastric biopsies, including those with known gastric pathology (e.g. auto-immune gastritis) or premalignant conditions (e.g patients under surveillance because of atrophic gastritis); * Age above 45 years old Exclusion Criteria: * History of previous gastrectomy; * History of endoscopic resection of neoplastic lesion * History of previous gastric dysplasia (even with no detectable lesion) * Hereditary syndromes that increase gastric cancer risk (familial adenomatous polyposis; Lynch syndrome) * Serious comorbidities (ASA 3 or more) * Medication with anticoagulants
Where it's running
-
IPO-Porto
Porto, Portugal Recruiting
Study contacts
- Principal investigator: Pedro Pimentel-Nunes, MD PhD — Instituto Português de Oncologia do Porto, Francisco Gentil
- Study coordinator: Pedro Pimentel-Nunes, MD PhD
- Email: pedro.nunes@ipoporto.min-saude.pt
- Phone: +35122508400
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting gastric cancer risk in patients with intestinal metaplasia and atrophic gastritis
This study is trying to find out which factors can help predict the risk of gastric cancer in patients who have intestinal metaplasia and atrophic gastritis.
-
Breath testing for gastric cancer screening
This study is testing if breath tests can help find gastric cancer and related conditions in people who have cancer, precancerous lesions, or are at average risk.
-
Mobile capsule gastroscopy for detecting stomach problems in older and high-risk people
This project will test if an AI-assisted swallowable camera (mobile capsule gastroscopy) can find stomach diseases in older adults and people at higher risk.
-
Registry and study on Helicobacter Pylori and related gastric conditions
This study is trying to track how Helicobacter pylori infections affect the development of stomach problems, like pre-cancerous changes and cancer, in adults over time.
-
Observational study on gastric precancerous conditions
This study looks at people who are at higher risk for stomach cancer to see how conditions like atrophic gastritis and intestinal metaplasia develop over time.
-
Monitoring patients with precancerous stomach lesions
This study is trying to find out how to better monitor people with precancerous stomach lesions to see who is at risk of developing gastric cancer and when they should come back for check-ups.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.